AGC Biologics Partners with Quell Therapeutics to Advance T-Cell Therapies Amid Stock Volatility
AGC Biologics has solidified its position in the biopharmaceutical industry through a strategic partnership with Quell Therapeutics, but its stock price has experienced volatility and its valuation multiples raise concerns.
2 minutes to read